Monte Rosa Therapeutics, Inc. ($GLUE)
Filing Information
| Accession Number | 0001193125-26-002385 |
|---|---|
| Form Type | 4 |
| Filing Date | Jan 5, 2026 |
| Document | View SEC Filing |
Transactions
3
Total Shares
196,155
Total Value
$47,861.35
P&L
+inf% (+$2,469,540.00)
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Chief Scientific Officer | Common Stock | โ | Jan 2, 2026 | Grant/Award | 35,000 | โ | โ | 71,000 | Direct | โ | View Details | |
Chief Scientific Officer | Common Stock | โ | Jan 5, 2026 | Sale | 3,155 | $15.17 | $47,861.35 | 67,845 | Direct | โ | View Details | |
Chief Scientific Officer | Stock Option (Right to Buy) | Derivative | Jan 2, 2026 | Grant/Award | 158,000 | $0.00 | $0.00 | 158,000 | Direct | โ | View Details |